Deutsches Institut für Zell- und Gewebeersatz (DIZG) is a leading non-profit institution in Europe that specializes in biotechnology, manufacturing, and pharmaceuticals. Founded in 1993, DIZG has been at the forefront of producing around 400,000 allogeneic tissue transplants since its inception, catering to a wide range of medical needs. Situated in the Innovation Park Wulheide, Germany, DIZG is committed to creating value for the medical industry by covering the entire value chain from R&D to manufacturing, marketing, and distribution of tissue transplants and cell cultures. The institute's mission is to promote tissue donation nationally and internationally while continuously conducting sustainable research and development to introduce new transplants. DIZG's dedication to providing life-changing solutions for areas such as accident surgery, plastic-reconstructive surgery, and oncological care underscores its commitment to advancing the field of tissue replacement. The company is actively seeking new employees to join its efforts and continue making strides in the field of tissue and cell replacement. With a strong track record and a clear vision for the future, DIZG is poised to remain a key player in the advancement of tissue and cell replacement technologies.
There is no investment information
No recent news or press coverage available for Deutsches Institut für Zell- und Gewebeersatz .